Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8722896
Prokineticin receptor antagonists and uses thereof
granted -
US 8722939
Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis
granted -
US 8722889
Azaindoles useful as inhibitors of JAK and other protein kinases
granted -
US 8722884
Pyrimidine derivatives for the treatment of abnormal cell growth
granted -
US 8722667
Compositions and methods for inhibiting the proliferation of cells
granted -
US 8722616
Anti-HIV peptides and methods of use thereof
granted -
US 8722077
Drug delivery coating for use with a stent
granted -
US 8722032
Thiol-selective water-soluble polymer derivatives
granted -
US 8722084
Controlled release preparation
granted -
US 8722628
Autophagy-inducing peptide
granted -
US 8722063
Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission
granted -
US 8722895
Prolyl hydroxylase inhibitors and method of use
granted -
US 8722653
Method for treating uterine fibroids
granted -
US 8721620
Swallowable drug delivery device and methods of drug delivery
granted -
US 8722082
Lipids and compositions for the delivery of therapeutics
granted -
US 8722646
High concentration chitosan-nucleic acid polyplex compositions
granted -
US 8722132
Application of a coating on a medical device
granted -
US 8722645
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
granted -
US 8722046
Human monoclonal antibodies protective against bubonic plague
granted -
US 8722662
Heterocyclic compounds
granted -
US 8722660
Heterocyclic compound
granted -
US 8716301
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted -
US 8716313
Crystalline forms of a biphenyl compound
granted -
US 8716315
Analogs of thalidomide as potential angiogenesis inhibitors
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.